Janux Therapeutics, Inc. (JANX)
13.61
-0.19
(-1.38%)
USD |
NASDAQ |
Feb 27, 16:00
13.61
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics EPS Diluted (Quarterly) : -0.514 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| Eli Lilly & Co. | 7.024 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| MannKind Corp. | -0.0519 |
| EyePoint Plc | -0.8513 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.95M |
| Total Expenses (Quarterly) | 31.95M |
| Enterprise Value | -125.82M |
| Earnings Yield | -13.47% |
| Normalized Earnings Yield | -13.47 |